Beckman Coulter Genomics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Beckman Coulter Genomics General Information

Description

Developer and provider of generation sequencing platform. The company offers a range of next generation sequencing services utilizing a combination of Illumina and Roche 454 next generation sequencing platforms.

Contact Information

Website
www.beckmangenomics.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 36 Cherry Hill Drive
  • Danvers, MA 01923
  • United States
+1 (978)
Primary Industry
Biotechnology
Acquirer
Genewiz
Vertical(s)
SaaS, TMT, Life Sciences
Corporate Office
  • 36 Cherry Hill Drive
  • Danvers, MA 01923
  • United States
+1 (978)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beckman Coulter Genomics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Beckman Coulter Genomics‘s full profile, request access.

Request a free trial

Beckman Coulter Genomics Patents

  • 175

    Total Documents Applications and Grants

  • Total Patents Families

  • 17

    Granted

  • Pending

  • Expiring in next 12 mo

Beckman Coulter Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100119235-A1 Methods and apparatus to deploy fiber optic based access networks Active 10-Nov-2008
US-8275262-B2 Methods and apparatus to deploy fiber optic based access networks Inactive 10-Nov-2008
CA-2622037-A1 Method for isolating nucleic acids Inactive 20-Sep-2005
EP-1937811-A1 Method for isolating nucleic acids Inactive 20-Sep-2005
WO-2007035750-A1 Method for isolating nucleic acids Inactive 20-Sep-2005 C12N15/1006
To view Beckman Coulter Genomics’s complete patent history, request access »

Beckman Coulter Genomics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Beckman Coulter Genomics‘s full profile, request access.

Request a free trial

Beckman Coulter Genomics FAQs

  • When was Beckman Coulter Genomics founded?

    Beckman Coulter Genomics was founded in 2008.

  • Where is Beckman Coulter Genomics headquartered?

    Beckman Coulter Genomics is headquartered in Danvers, MA.

  • What industry is Beckman Coulter Genomics in?

    Beckman Coulter Genomics’s primary industry is Biotechnology.

  • Is Beckman Coulter Genomics a private or public company?

    Beckman Coulter Genomics is a Private company.

  • What is Beckman Coulter Genomics’s current revenue?

    The current revenue for Beckman Coulter Genomics is .

  • Who are Beckman Coulter Genomics’s investors?

    Beckman Coulter has invested in Beckman Coulter Genomics.

  • When was Beckman Coulter Genomics acquired?

    Beckman Coulter Genomics was acquired on 21-Dec-2015.

  • Who acquired Beckman Coulter Genomics?

    Beckman Coulter Genomics was acquired by Genewiz.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process